BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26337114)

  • 21. Intellectual property. Supreme Court rules out patents on 'natural' genes.
    Marshall E
    Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?).
    Gordon J
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a020917. PubMed ID: 25502748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of the evolution of the written description requirement vis-à-vis DNA and biotechnological inventions.
    Greenbaum D
    Recent Pat DNA Gene Seq; 2007; 1(2):138-44. PubMed ID: 19075928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Have you bargained away patent rights? Inventors and entrepreneurs need to consider a recent Supreme Court ruling in their patent strategies.
    Baggot B
    Nat Biotechnol; 1999 Mar; 17(3):297-8. PubMed ID: 10096300
    [No Abstract]   [Full Text] [Related]  

  • 25. The clones war.
    Nuell MJ; Nuell MJ
    Food Drug Law J; 2011; 66(1):47-72, i-ii. PubMed ID: 24505846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genes can't be patented, rules Supreme Court.
    McCarthy M
    BMJ; 2013 Jun; 346():f3907. PubMed ID: 23771229
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of America Invents Act on Biotech Intellectual Property.
    Murphy A; Stramiello M; Stroud J; Lewis S; Irving T
    Cold Spring Harb Perspect Med; 2015 Apr; 5(9):a020784. PubMed ID: 25918182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicine.
    Aboy M; Crespo C; Liddell K; Minssen T; Liddicoat J
    Nat Biotechnol; 2019 May; 37(5):513-518. PubMed ID: 31053817
    [No Abstract]   [Full Text] [Related]  

  • 29. Patentability of genetically engineered microorganisms.
    Cooper A
    JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monsters at the patent office: the inconsistent conclusions of moral utility and the controversy of human cloning.
    Smith AR
    De Paul Law Rev; 2003; 53(1):159-203. PubMed ID: 15568254
    [No Abstract]   [Full Text] [Related]  

  • 31. The prodigal son: the relationship between patent law and health care.
    Bostyn SJ
    Med Law Rev; 2003; 11(1):67-120. PubMed ID: 14606473
    [No Abstract]   [Full Text] [Related]  

  • 32. KSR v. Teleflex. Part 1: Impact of U.S Supreme Court Patent Law on Canadian intellectual property and regulatory rights landscape.
    Bouchard RA
    Health Law J; 2007; 15():221-46. PubMed ID: 19702184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The quest for market exclusivity in biotechnology: navigating the patent minefield.
    Gersten DM
    NeuroRx; 2005 Oct; 2(4):572-8. PubMed ID: 16489366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents.
    Teitelbaum R; Cohen M
    Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990
    [No Abstract]   [Full Text] [Related]  

  • 35. Patent office decisions strengthened by Supreme Court.
    Baggot BX
    Nat Biotechnol; 1999 Nov; 17(11):1131-2. PubMed ID: 10545924
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
    Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
    J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the factors that result in obviousness rulings for biotech patents: an updated analysis of the US Federal Circuit decisions after KSR.
    Lin F; Wang SJ
    Hum Vaccin Immunother; 2013 Nov; 9(11):2490-5. PubMed ID: 23899509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotech patents: looking backward while moving forward.
    Eisenberg RS
    Nat Biotechnol; 2006 Mar; 24(3):317-9. PubMed ID: 16525404
    [No Abstract]   [Full Text] [Related]  

  • 39. [U.S. Supreme Court ruling on patentability of genes].
    Darío Bergel S
    Rev Derecho Genoma Hum; 2013; (39):99-118. PubMed ID: 24868959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intellectual Property in Genetic Material.
    Gatley I
    J Bioeth Inq; 2015 Dec; 12(4):561-4. PubMed ID: 26691916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.